Source Search Page
bioworld.com > articles
Gilead latest as all PD-1 agonist boats lifted by rising tide
4+ hour, 38+ min ago —...Upgrade your daily dose of biopharma and medtech news Gilead latest...
bioworld.com > articles
PARP-1 inhibitor HH-102007 shows synergy with carboplatin for cancer treatment
13+ hour, 21+ min ago — bioworld.com > articles
Diagnostics key in Acrivon, Boundless ovarian face-off?
10+ hour, 21+ min ago —...daily dose of biopharma and medtech news Diagnostics key in Acrivon...
bioworld.com > articles
Billiontoone test reduces need for Rhogam in 40% of Rh-negative pregnancies
10+ hour, 21+ min ago — bioworld.com > articles
Space Liintech raises ₩4B in series A to launch drug R&D to space
6+ hour, 17+ min ago — bioworld.com > articles
HSK-42360, a BRAF paradox breaker with efficacy in models of brain metastasis and BRAF-inhibitor resistance...
12+ hour, 9+ min ago —...dose of biopharma and medtech news HSK-42360, a BRAF paradox breaker...
bioworld.com > articles
Synedgen completes IND-enabling studies for lead candidate
13+ hour, 21+ min ago —...medtech news Synedgen completes IND-enabling studies for lead candidate...
bioworld.com > articles
Pfizer’s Beqvez taking on Hemgenix with FDA nod in hemophilia B
12+ hour, 24+ min ago —...Beqvez, which nabbed its first approval from Health Canada in January... ...Pfizer Inc.’s Beqvez (fidanacogene elaparvovec) won FDA approval... ...officer and executive vice president at Pfizer.... ...(later acquired by Roche AG), also is under review in Europe....
bioworld.com > articles
Shanghai Jemincare Pharmaceuticals patents new androgen receptor antagonists
1+ day ago —...Upgrade your daily dose of biopharma and medtech news Shanghai Jemincare... ...Pharmaceuticals patents new androgen receptor antagonists...